Since launching a dedicated clinical trials unit, Walgreens has approached over 17 million individuals about participating in drug studies, resulting in a 20% higher enrollment rate compared to traditional referral sources. Their community-based research model emphasizes accessibility and inclusivity, with a majority of outreach to women, underrepresented groups, and older adults. Collaborations with pharma companies, such as AstraZeneca, leverage Walgreens' insights into community engagement and patient outreach, positioning the pharmacy giant as a vital player in clinical research participation enhancement.